Accede al análisis completo con tu suscripción
Últimos 20 reportes · 10-K · 10-K/A · 10-Q · 8-K · Fuente: SEC EDGAR
Accede al análisis completo con tu suscripción
SEC CIK: 0001121404
Sanofi is an R&D driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. We apply our deep understanding of the immune system to invent medicines and vaccines that treat and protect millions of people around the world, with an innovative pipeline that could benefit millions more. Our team is guided by one purpose: we chase the miracles of science to improve people’s lives; this inspires us to drive progress and deliver positive impact for our people and the communities we serve, by addressing the most urgent healthcare, environmental, and societal challenges of our time. In the remainder of this section, medicines and vaccines are referred to either by their international non-proprietary name (INN) or their brand name, which is generally exclusive to the company that markets it. In most cases, the brand names of our medicines and vaccines, which may vary from country to country, are protected by specific registrations. In this document, medicines and vaccines are identified by their brand names used in France and/or in the US. T he segment information presented by Sanofi consists of a single operating segment: Biopharma.
Ver másConsenso de Analistas
Precio Objetivo — 12 meses
$44.00
Mínimo
-1.7%
$54.50
Mediana
+21.7%
$53.48
Promedio
+19.5%
$63.00
Máximo
+40.7%
| Métrica | FY 2025 | 2024 | 2023 | 2022 | 🔒Premium | 🔒Premium | 🔒Premium | 🔒Premium | 🔒Premium | 🔒Premium | 🔒Premium |
|---|---|---|---|---|---|---|---|---|---|---|---|
| INGRESOS Y MÁRGENES | |||||||||||
| Ingresos Totales | 46.716B | 44.286B | 41.618B | 40.561B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Coste de Ventas | 13.049B | 13.205B | 12.628B | 11.882B | 🔒 | 🔒 | |||||
Cifras en miles de millones (B) · Fuente: SEC/EDGAR
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| Beneficio Bruto | 33.667B | 31.081B | 28.990B | 28.679B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| I+D Y GASTOS OPERATIVOS | |||||||||||
| I+D recurrente | 7.842B | 7.394B | 6.507B | 6.501B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| SG&A | 9.543B | 9.183B | 8.933B | 8.739B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Amortización de intangibles | 1.776B | 1.749B | 1.911B | 1.804B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Reestructuración | 1.138B | 1.396B | 1.030B | 1.077B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Stock-Based Compensation | 313.000M | 278.000M | 260.000M | 234.000M | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| RESULTADO OPERATIVO | |||||||||||
| EBIT (pretax + intereses) | 6.506B | 7.357B | 6.667B | 10.354B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Operating Income (publicado) | 6.344B | 7.252B | 6.960B | 10.162B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| NOPAT (numerador del ROIC) | 5.379B | 6.110B | 5.896B | 8.777B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| RESULTADO NETO | |||||||||||
| Resultado antes de impuestos | 6.020B | 6.758B | 6.115B | 9.992B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Gastos por intereses | 486.000M | 599.000M | 552.000M | 362.000M | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Impuesto sobre beneficios | 1.043B | 1.204B | 1.017B | 1.909B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Beneficio Neto | 7.813B | 5.560B | 5.400B | 8.371B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Operaciones interrumpidas | 2.874B | 64.000M | 338.000M | 401.000M | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| BPA Diluido | 6.37 | 4.43 | 4.30 | 6.66 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| BPA Básico | 6.40 | 4.44 | 4.31 | 6.69 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| CAPITAL CIRCULANTE | |||||||||||
| Existencias | 10.214B | 9.431B | 9.666B | 8.960B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Clientes | 8.410B | 7.677B | 8.433B | 8.424B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Proveedores | 7.361B | 7.551B | 7.328B | 6.813B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Activo Corriente | 30.952B | 42.588B | 30.670B | 34.111B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Pasivo Corriente | 28.345B | 29.162B | 24.207B | 23.974B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Capital Circulante | 2.607B | 13.426B | 6.463B | 10.137B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| LIQUIDEZ | |||||||||||
| Efectivo y equivalentes | 7.657B | 7.441B | 8.710B | 12.736B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Liquidez Total | 7.657B | 7.441B | 8.710B | 12.736B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| BALANCE — ACTIVOS | |||||||||||
| Inmovilizado material (neto) | 10.052B | 10.091B | 10.160B | 9.869B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Fondo de comercio | 41.300B | 43.384B | 49.404B | 49.892B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Intangibles | 26.261B | 22.629B | 24.319B | 21.640B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Activo Total | 126.805B | 132.798B | 126.464B | 126.722B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Pasivo Total | 55.095B | 54.941B | 52.111B | 51.570B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Pasivo por arrendamientos | 1.739B | 1.906B | 2.030B | 2.181B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| CAPITAL Y DEUDA | |||||||||||
| Deuda a largo plazo | 14.248B | 11.791B | 14.347B | 14.857B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Deuda a corto plazo | 4.342B | 4.209B | 2.045B | 4.174B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Deuda Total | 18.590B | 16.000B | 16.392B | 19.031B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Deuda Neta | 10.933B | 8.559B | 7.682B | 6.295B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Patrimonio Neto | 71.376B | 77.507B | 74.040B | 74.784B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Interés minoritario | 334.000M | 350.000M | 313.000M | 368.000M | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Capital Invertido | 82.643B | 86.416B | 82.035B | 81.447B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Acciones en Circulación | 1.219B | 1.263B | 1.265B | 1.261B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| FLUJO DE CAJA Y RETRIBUCIÓN AL ACCIONISTA | |||||||||||
| Flujo de Caja Operativo | 10.561B | 8.607B | 9.271B | 9.638B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Adquisiciones de negocios | 9.394B | 1.901B | 2.535B | 987.000M | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Dividendos pagados | 4.772B | 4.704B | 4.454B | 4.168B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Dividendo por acción | 3.92 | 3.76 | 3.56 | 3.33 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Recompras de acciones | 5.030B | 302.000M | 593.000M | 497.000M | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| RATIOS | |||||||||||
| ROIC (NOPAT / capital invertido) | 6.5% | 7.1% | 7.2% | 10.8% | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Margen Neto (continuadas) | 10.6% | 12.4% | 12.2% | 19.6% | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Current Ratio | 1.09x | 1.46x | 1.27x | 1.42x | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Debt / Equity Ratio | 0.26x | 0.21x | 0.22x | 0.25x | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| I+D / Ingresos | 16.8% | 16.7% | 15.6% | 16.0% | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Gross Margin | 72.1% | 70.2% | 69.7% | 70.7% | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Margen EBIT | 13.9% | 16.6% | 16.0% | 25.5% | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Operating Margin (publicado) | 13.6% | 16.4% | 16.7% | 25.1% | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Crecimiento Ingresos | 5.5% | 6.4% | 2.6% | — | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Amort. intangibles / Ingresos | 3.8% | 4.0% | 4.6% | 4.5% | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| SG&A / Ingresos | 20.4% | 20.7% | 21.5% | 21.6% | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| SBC / Ingresos | 0.7% | 0.6% | 0.6% | 0.6% | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| ROE (beneficio total) | 10.5% | 7.3% | 7.3% | 11.7% | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| ROA (beneficio total) | 6.0% | 4.3% | 4.3% | 6.8% | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Effective Tax Rate | 17.3% | 17.8% | 16.6% | 19.1% | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Quick Ratio | 0.57x | 0.56x | 0.71x | 0.88x | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Interest Coverage | 13.39x | 12.28x | 12.08x | 28.60x | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Coste medio de la deuda | 2.6% | 3.7% | 3.4% | 1.9% | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Deuda / Total Activos | 14.7% | 12.1% | 13.0% | 15.0% | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Fondo de comercio + intangibles / Activo | 53.3% | 49.7% | 58.3% | 56.5% | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Días de inventario | 285.7 d | 260.7 d | — | — | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Días de cobro (DSO) | 65.7 d | 63.3 d | — | — | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Días de pago (DPO) | 205.9 d | 208.7 d | — | — | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Ciclo de conversión de caja | 145.5 d | 115.3 d | — | — | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Payout (BPA con discont.) | 61.5% | 84.9% | 82.8% | 50.0% | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
Precio actual · USD
$44.87
ROIC (NOPAT / capital invertido)
6.5%
Margen Neto (continuadas)
10.6%
Current Ratio
1.09x
Debt / Equity Ratio
0.26x
I+D / Ingresos
16.8%
Gross Margin
72.1%
Margen EBIT
13.9%
Operating Margin (publicado)
13.6%